Verily
Healthcare AI
precision health platform, clinical research AI, care delivery AI, population health
Series X
Verily is an Alphabet-backed precision health company that develops an AI-native platform and solutions for organizing, analyzing, and deploying biomedical data across research, care, and public health workflows. Its current platform, Verily Pre, is designed to help customers harmonize healthcare data, build and deploy AI models and agents, and support precision health applications such as clinical research and personalized care.
Company Details
- Website
- verily.com
- Headquarters
- Dallas, Texas, United States
- Founded
- 2015
- Funding
- $300M+
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring